Arisan Therapeutics
UEI: PYRKTQPNVJZ8
• CAGE: 616D2
Overview
Awardee Type
Parent
Keywords
Emerging virus, Arenavirus, Ebola, therapeutic, diagnostic, dengue, Zika
Name
Arisan Therapeutics
Headquarters
Carlsbad, CA
United States
United States
Most Recent Award
Sept. 22, 2023
Calculating
Federal contract and grant recipient
ARISAN THERAPEUTICS INC
(UEI PYRKTQPNVJZ8, CAGE 616D2)
is headquartered in Carlsbad CA.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in May 2010 and
federally registered in
June 2010.
Federal Award Analysis
Arisan Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ARISAN THERAPEUTICS INC
UEI
PYRKTQPNVJZ8
CAGE Code
616D2
Primary NAICS
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 5, 2010
Initial Registration
June 11, 2010
Last Registration
Jan. 22, 2025
Registration Activation
Jan. 22, 2025
Registration Expiration
Jan. 17, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No